People

Raymond Sanchez
Has been an Alto director since August 2025. Previously chief medical officer at Cerevel and a clinical development leader at Otsuka and Avanir. His current Alto biography also identifies a senior adviser role at Bain Capital Life Sciences and a Rapport board role.
Roles
Kasvu Therapeutics
CurrentScientific Advisory Board Member
Iaso Ventures
CurrentAdvisor, Drug Development
Sensorium Therapeutics
CurrentScientific and Clinical Advisor
Alto Neuroscience
CurrentBoard Director